Vapreotide API is a pharmaceutical-grade synthetic somatostatin analogue designed to mimic the biological activity of endogenous somatostatin while providing a longer duration of action. It binds selectively to somatostatin receptors, suppressing the secretion of numerous hormones and peptides, including growth hormone, glucagon, insulin, and various gastrointestinal hormones.
Vapreotide has been used in the management of acute esophageal variceal bleeding, neuroendocrine tumors, acromegaly, and other endocrine and gastrointestinal disorders where inhibition of hormone secretion is beneficial. Its ability to reduce splanchnic blood flow also makes it valuable in controlling bleeding associated with portal hypertension.
Manufactured under WHO-GMP-certified facilities, our Vapreotide API is produced using advanced peptide synthesis and purification technologies to ensure exceptional purity, biological activity, stability, and batch-to-batch consistency. Every batch undergoes stringent quality testing and is supplied with complete regulatory documentation including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Vapreotide API is used in injectable pharmaceutical formulations for managing acute esophageal variceal bleeding, neuroendocrine tumors, acromegaly, and other endocrine and gastrointestinal disorders.
Vapreotide binds to somatostatin receptors, suppressing the release of multiple hormones and reducing splanchnic blood flow, helping control hormone-related disorders and gastrointestinal bleeding.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Vapreotide API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp